Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antioxidant and Anti-Inflammatory Effects of 6,3',4´- and 7,3´,4´-Trihydroxyflavone on 2D and 3D RAW264.7 Models. | Antioxidants (Basel) | 2023 | 36671068 | PubTator, text mining | PubMed |
| Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learning. | Commun Med (Lond) | 2023 | 36670203 | PubTator, text mining | PubMed |
| Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis? | Curr Rheumatol Rep | 2023 | 36652160 | PubTator, text mining | PubMed |
| Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. | Cell Death Discov | 2023 | 36646672 | PubTator, text mining | PubMed |
| Immunomodulatory IL-23 receptor antagonist peptide nanocoatings for implant soft tissue healing. | Dent Mater | 2023 | 36642687 | PubTator, text mining | PubMed |
| Immunity to the microbiota promotes sensory neuron regeneration. | Cell | 2023 | 36640762 | PubTator, text mining | PubMed |
| Single-cell profiling identifies ACE+ granuloma macrophages as a nonpermissive niche for intracellular bacteria during persistent Salmonella infection. | Sci Adv | 2023 | 36608122 | PubTator, text mining | PubMed |
| Immune responses to human fungal pathogens and therapeutic prospects. | Nat Rev Immunol | 2023 | 36600071 | PubTator, text mining | PubMed |
| Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors. | Dermatol Ther (Heidelb) | 2023 | 36592300 | PubTator, text mining | PubMed |
| Aptamer Technology and Its Applications in Bone Diseases. | Cell Transplant | 2023 | 36591965 | PubTator, text mining | PubMed |
| Promotion of IL‑17/NF‑κB signaling in autoimmune thyroid diseases. | Exp Ther Med | 2023 | 36588813 | PubTator, text mining | PubMed |
| Kidney-resident innate-like memory γδ T cells control chronic Staphylococcus aureus infection of mice. | Proc Natl Acad Sci U S A | 2023 | 36574651 | PubTator, text mining | PubMed |
| The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? | Blood Adv | 2023 | 36574293 | PubTator, text mining | PubMed |
Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study. | Dermatol Ther (Heidelb) | 2023 | 36566344 | PubTator, text mining | PubMed |
| Alopecia Areata in Latin America: Where are We and Where are We Going? | Dermatol Ther (Heidelb) | 2023 | 36527577 | PubTator, text mining | PubMed |
| Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting. | Adv Ther | 2023 | 36515803 | PubTator, text mining | PubMed |
| Brodalumab: Efficacy, safety, and survival in mid-term (52 weeks) on real clinical practice in Andalucia, Spain. | Int J Dermatol | 2023 | 36495585 | PubTator, text mining | PubMed |
| Sounding the alarmins-The role of alarmin cytokines in asthma. | Allergy | 2023 | 36463491 | PubTator, text mining | PubMed |
| A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites. | Immunobiology | 2023 | 36434912 | PubTator, text mining | PubMed |
| BlpC-mediated selfish program leads to rapid loss of Streptococcus pneumoniae clonal diversity during infection. | Cell Host Microbe | 2023 | 36395758 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=37